Incredible! NYT pushing toxic cancer drugs for healthy women who have no cancer
(NaturalNews) A taxpayer-funded government task force has issued new guidelines that literally
urge healthy women to take toxic cancer drugs "preventively" in order to
allegedly decrease their risk of developing breast cancer. As recently
promoted by
The New York Times (NYT), these shocking new recommendations from the U.S.
Preventive Services Task Force (USPSTF) have been issued despite a complete lack of evidence that the
dangerous cancer drugs being recommended have any preventive efficacy
whatsoever.
Fortifying earlier recommendations from 2002 that
encouraged both tamoxifen and raloxifene as so-called preventive breast
cancer treatment, USPSTF now says that healthy women with either a
personal or family history of breast cancer, or who are considered "high
risk," should consider taking either of the two drugs for at least five
years, even though doing so could cause major side effects like blood
clots or stroke. USPSTF is also now pressing doctors to being actively
prescribing such drugs to their healthy female patients, and
particularly those between the ages of 40 and 70.
The task force
says it recently evaluated a host of new data on the subject of breast
cancer prevention and determined that taking either tamoxifen or
raloxifene while healthy may help block estrogen, a hormone that feeds
roughly 75 percent of the type of breast cancers that women today face.
The group estimates that for every 1,000 healthy women who take either
of the two
drugs, roughly eight of them will avoid developing breast cancer in the following five years.
Target group for preventive cancer therapy will not even benefit from it, admits reportHowever,
as many as seven additional women per 1,000 taking tamoxifen or
raloxifene will also admittedly develop blood clots during the same time
frame, according to the report, while about four others per 1,000 will
develop uterine
cancer from the drugs. These figures represent a doubled risk of both
conditions as a result of taking either of the two drugs preventively
rather than doing nothing at all, which means millions of women are now
at substantial health risk due to USPSTF's recommendations.
Beyond
this, the very target group that USPSTF is now urging to take cancer
drugs preventively is actually the least likely to derive any benefits
from the "treatment." As it turns out, the vast majority of healthy
women considered to be at high risk of developing
breast cancer will never develop breast cancer, according to the report. And most
breast cancer cases occur in women who were never identified as being
"high risk" in the first place, which makes USPSTF's new recommendations
laughable.
"Most
women identified as 'high risk' will not develop breast cancer," explains the
report, which also duplicitously states that "high risk," healthy women
should be first in line to take the drugs preventively. "[T]he majority
of breast cancer cases will arise in women who are not identified as
having increased risk."
Let your voice be heard: Comment on proposed new guidelines before May 13The
primary entity that will benefit from USPSTF's obvious affront to
common sense is the cancer industry, which will have the opportunity to
sell its toxic cancer pills to a whole new market of
healthy women that do not need them. The losers, of course, will be those
gullible members of the public that fall for the ridiculous shenanigan.
But
you can help stop the recommendations from gaining official status by
making your voice heard on the published draft form. Public comments
will be accepted until May 13, and you can leave them at the following
link:
http://www.uspreventiveservicestaskforce.org/draftrec4.htmSource:-
http://www.naturalnews.com/040106_breast_cancer_New_York_Times_treatment.html